205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.84%
Revenue growth 1.25-1.5x INTC's 7.90%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
16.44%
Gross profit growth 1.25-1.5x INTC's 14.32%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
26.41%
EBIT growth above 1.5x INTC's 17.03%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
13.75%
Operating income growth at 75-90% of INTC's 17.03%. Bill Ackman would demand a plan to enhance operating leverage.
0.48%
Positive net income growth while INTC is negative. John Neff might see a big relative performance advantage.
2.63%
EPS growth of 2.63% while INTC is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
No Data
No Data available this quarter, please select a different quarter.
-0.55%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.36%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-99.94%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
83.07%
OCF growth above 1.5x INTC's 46.90%. David Dodd would confirm a clear edge in underlying cash generation.
86.67%
FCF growth similar to INTC's 94.82%. Walter Schloss would attribute it to parallel capital spending and operational models.
-2.77%
Negative 10Y revenue/share CAGR while INTC stands at 180.15%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
20.39%
5Y revenue/share CAGR at 75-90% of INTC's 26.44%. Bill Ackman would encourage strategies to match competitor’s pace.
68.07%
3Y revenue/share CAGR similar to INTC's 67.89%. Walter Schloss would assume both companies experience comparable short-term cycles.
175.37%
10Y OCF/share CAGR under 50% of INTC's 673.75%. Michael Burry would worry about a persistent underperformance in cash creation.
228.76%
5Y OCF/share CAGR above 1.5x INTC's 60.66%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
182.00%
3Y OCF/share CAGR above 1.5x INTC's 100.19%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
102.53%
Net income/share CAGR at 50-75% of INTC's 151.40%. Martin Whitman might question if the firm’s product or cost base lags behind.
-1.52%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
253.22%
3Y net income/share CAGR 1.25-1.5x INTC's 218.83%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
186.13%
10Y equity/share CAGR at 50-75% of INTC's 286.74%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
1.13%
Below 50% of INTC's 7.81%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
12.65%
3Y equity/share CAGR similar to INTC's 13.88%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
-99.93%
Cut dividends over 10 years while INTC stands at 1627.82%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-99.92%
Negative 5Y dividend/share CAGR while INTC stands at 299.02%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-99.93%
Negative near-term dividend growth while INTC invests at 300.62%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
0.68%
AR growth is negative/stable vs. INTC's 8.70%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-3.66%
Inventory is declining while INTC stands at 2.77%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.44%
Asset growth above 1.5x INTC's 1.82%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.15%
Positive BV/share change while INTC is negative. John Neff sees a clear edge over a competitor losing equity.
-0.83%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
6.90%
R&D dropping or stable vs. INTC's 14.03%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
20.35%
SG&A growth well above INTC's 10.13%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.